Table 2.
Genotype
|
Mutant protein
|
Viability
|
Viability with reduced cyclin E dose
|
Eggshell morphology
|
Inappropriate genomic replication
|
Amplification (BrdU foci)
|
ORC2 foci
|
---|---|---|---|---|---|---|---|
dE2F91 | − | −a | N.D. | N.D. | N.D. | N.D. | |
DNALeucineActivation & | |||||||
bindingzipperRb binding | |||||||
dE2Fi1 | + | − | thin | no | −/+b | − | |
DNALeucine | |||||||
bindingzipper | |||||||
dE2Fi2 | + | + | thick | no | ++c | + | |
DNA | |||||||
binding | |||||||
dDPa1 | + | N.D. | very thin | yes | − | −d |
These animals die earlier in development with a twofold reduction of the zygotic cyclin E contribution.
(−/+) Reduced, but not absent, levels of amplification.
(++) Increased levels of amplification relative to wild type.
Uniform nuclear ORC2 localization persists inappropriately.